Zusammenfassung
Durch die Einführung der Methoden zur Blutzuckerselbstkontrolle ist es Patienten mit Typ-I-Diabetes prinzipiell möglich geworden, unter ambulanten Bedingungen die Blutzuckerwerte zu normalisieren. Erste eindrucksvolle Behandlungserfolge wurden mit schwangeren Diabetikerinnen erzielt. So zeigten Jovanovic et al. [1], daß während der gesamten Schwangerschaft mittlere Blutzuckerwerte von etwa 90 mg% ohne erhöhtes Risiko schwerer Unterzuckerungen erreichbar sind. Durch Normoglykämie während der Schwangerschaft lassen sich fetale Makrosomie und assoziierte Komplikationen vermeiden [1, 2]. Normoglykämie bereits vor der Konzeption und während der Schwangerschaft reduziert die Hyperglykämie-assoziierte Mißbildungsrate bei Kindern diabetischer Mütter [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Jovanovic L, Peterson CM, Saxena BB, Dawood MY, Saudeck CD (1980) Feasibility of maintaining normal glucose profiles in insulin-dependent pregnant diabetic women. Am J Med 68: 105–112
Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glöckner E (1983) Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 6: 219–223
Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1988) Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260: 2864–2871
Feingold KR, Lee TH, Chung MY, Siperstein MD (1986) Muscle capillary basement membrane with in patients with vacor-induced diabetes mellitus. J Clin Invest 78: 102–107
Couet C, Genton P, Pointel JP et al. (1985) The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care 8: 323–328
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25: 496–501
Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596
Dwyer MS, Melton LJ, Ballard DJ, Palumbo PJ, Trautmann JC, Chu SP (1985) Incidence of diabetic retinopathy and blindness: A population-based study in Rochester, Minnesota. Diabetes Care 8: 316–322.
Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR (1986) Risk of proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: A 40-year follow-up study. Diabetes Care 9: 443–452
Borch-Johnsen K, Nissen H, Henriksen E, Kreiner S, Sailing N, Deckert T, Nerup J (1987) The natural history of insulin-dependent diabetes mellitus in Denmark: 1. long-term survival with and without late diabetic complications. Diabetic Med 4: 201–210
Pirart J (1978) Diabetes mellitus and its degenerative complications: A prospective study of 4.400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188
Weber B, Burger W, Hartmann R, Hovener G, Malchus R, Oberdisse U (1986) Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29: 23–29
Chantelau E, Weiss H, Weber U, Sonnenberg GE, Berger M (1988) Four-year follow-up of retinal status and glycosylated haemoglobin in patients with insulin-dependent diabetes mellitus. Diabete Metabolisme 14: 259–263
Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O’Brien D (1989) Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 261:1155–1160
McCance DR, Hadden DR, Atkinson AB, Archer DB, Kennedy L (1989) Long-term glycaemic control and diabetic retinopathy. Lancet II: 824–828
Raskin P, Pietri AO, Unger R, Shannon WA (1983) The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with type 1 diabetes mellitus. N Engl J Med 309: 1546–1550
Rosenstock J, Friberg T, Raskin P (1986) Effect of glycemic control on microvascular complications in patients with type 1 diabetes mellitus. Am J Med 81: 1012–1018
Muhlhauser I, Bruckner J, Howorka K (1987) Near-normoglycaemia and microvascular complications. Diabetologia 30: 47–48
Hanssen KF, The DCCT Research Group, Brunetti P (1988) Is there a need for a continuation of the DCCT in 1988? Diab Nutr Metab 1: 151–159
Hanssen KF, Dahl-Jorgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986) Diabetic control and microvascular complications: The near-normoglycaemic experience. Diabetologia 29: 677–684
Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O, Aker Diabetes Group (1985) Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: The Oslo study. Br Med J 290: 811–815
Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study. Br Med J 293: 1195–1199
Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L (1988) The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. Arch Ophthalmol 106: 1242–1246
Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L, Oslo Study Group (1985) Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 100: 644–653
Brinchmann-Hanssen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L (1988) Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment. Ophthalmology 95: 1358–1366
Rosenlund EF, Haakens K, Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF (1988) Transient proliferative diabetic retinopathy during intensified insulin treatment. Am J Ophthalmol 105: 618–625
Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L (1986) Effects of intensified insulin treatment on retinal vessels in diabetic patients. Br J Ophthalmol 72: 666–673
Dahl-Jorgensen K, Hanssen KF, Kierulf P, Bjoro R, Sandvik L, Aagenaes O (1988) Reduction of urinary albumin excretion after 4 years of continuous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. Acta Endocrinol 117:19–25
The DCCT Research Group (1987) Diabetes Control and Complications Trial (DCCT): Results of the feasibility study. Diabetes Care 10: 1–19
Feldt-Rasmussen B, Jensen T, Lauritzen T, Mathiesen ER, Deckert T (1989) Association of poor metabolic control for five to eight years and progression of diabetic renal disease. Diabetologia 32: 486–487
Service FJ, Rizza RA, Daube JR, O’Brien PC, Dyck PJ (1985) Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727
Ramsay RC, Goetz FC, Sutherland DER et al. (1988) Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 318: 208–214
Sutherland DER, Kendall DM, Moudry KC et al. (1988) Pancreas transplantation in nonuremic, type 1 diabetic recipients. Surgery 104: 453–464
Viberti GC, Bilous RW, Mackintosh D, Bending H, Keen H (1983) Long term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J 286: 598–602
Bending JJ, Viberti GC, Watkins PJ, Keen H (1986) Intermittent clinical proteinuria and renal function in diabetes: Evolution and the effect of glycaemic control. Br Med J 292: 83–86
Nyberg G, Blohme G, Norden G (1987) Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia 30: 82–86
Parving H-H, Hommel E (1989) Prognosis in diabetic nephropathy. Br Med J 299: 230–233
Bohman SO, Tyden G, Wilczek H et al. (1985) Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 34: 306–308
Maurer SM, Goetz FC, McHugh LE, Sutherland DER, Barbosa J, Najarian JS, Steffes MW (1989) Long-term study of normal kidneys transplanted into patients with type 1 diabetes. Diabetes 38: 516–523
Bilous RW, Maurer SM, Sutherland DER, Najarian JS, Goetz FC, Steffes MW (1989) The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-depdendent diabetes. N Engl J Med 321: 80–85
Nelson RG, Newman JM, Knowler WC et al. (1988) Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31: 730–736
Siperstein MD (1988) Diabetic microangiopathy, genetics, environment and treatment. Am J Med 85 (Suppl 5A): 119–130
Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC (1989) Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes 38: 435–440
Nathan DM, Singer DE, Godine JE, Perlmuter LC (1986) Non-insulin-dependent diabetes in older patients. Am J Med 81: 837–842
Geiss LS, Herman WH, Teutsch SM (1985) Diabetes and renal mortality in the United States. Am J Public Health 75: 1325–1326
Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT (1982) The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Internat 21: 730–738
Feutren G, Papoz L, Assan R et al. (1986) Cyclosporin increases the rate and length of remission in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet II: 119–124
The Canadian-European Randomized Control Trial Group (1988) Cyclosporin-induced remission of IDDM after early intervention. Association of 1 year of cyclosporin treatment with enhanced insulin secretion. Diabetes 37: 1574–1582
Wilson MR, Clarke P, Barkes H, Heller SR, Tattersaal RB (1986) Starting insulin treatment as an outpatient. Report of 100 consecutive patients followed up for at least one year. JAMA 256: 877–880
Gründler J (1987) Evaluation des Diabetes Therapie- und Schulungsprogramms bei Patienten mit Erstmanifestation eines Typ-I-Diabetes. Eine Nachuntersuchung der zwischen Januar 1979 und Juni 1983 in der Abteilung Stoffwechsel und Ernährung der Medizinischen Klinik der Universität Düsseldorf behandelten Patienten. Medizinische Doktorarbeit, Universität Düsseldorf 1987
Klur K (1989) Evaluation eines einwöchigen Diabetes-Behandlungs- und Schulungsprogramms bei erstmanifestierten Typ 1 Diabetikern/Remission beim Typ 1 Diabetes mellitus. Medizinische Doktorarbeit, Universität Düsseldorf 1989
Lewin R (in Vorbereitung) Nachuntersuchung der zwischen Januar 1987 und Juni 1988 in der Abteilung Stoffwechsel und Ernährung der Medizinischen Klinik der Universität Düsseldorf behandelten Patienten mit frisch manifestiertem Typ 1 Diabetes
Muhlhauser I, Jorgens V, Berger M et al. (1983) Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: Improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25: 470–476
Berger M, Jorgens V, Muhlhauser I, Zimmermann H (1983) Die Bedeutung der Diabetiker- schulung in der Therapie des Typ-I-Diabetes. Dtsch Med Wochenschr 108: 424–430
Schiffrin A, Desrosiers M, Moffat M, Belmonte MM (1983) Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. J Pediatr 103: 522–527
Rudolf MC, Ahern JA, Genel M et al. (1982) Optimal insulin delivery in adolescents with diabetes: Impact of intensive treatment on psychological adjustment. Diabetes Care 5 (Suppl 1): 53–75
Muhlhauser I, Berger M, Sonnenberg G, Koch J, Jorgens V, Schernthaner G, Scholz V (1985) Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 8: 268–273
Assal JP, Muhlhauser I, Pernet A, Gfeller R, Jorgens V, Berger M (1985) Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28: 602–613
Muhlhauser I, Bruckner I, Berger M et al. (1987) Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Dusseldorf Study. Diabetologia 30: 681–690
Muhlhauser I, Santiago JV, Bolli GB (1988) The frequency of severe hypoglycaemia during intensive insulin therapy. Diab Nutr Metab 1: 77–88
Howorka K (1987) Funktionelle, nahe-normoglykamische Insulinsubstitution. Lerninhalte, Praxis und Didaktik. Springer Berlin Heidelberg New York Tokyo
White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV (1983) Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308: 485–491
Berger W, Keller U, Honegger B, Jaeggi E (1989) Warning symptoms of hypoglycaemia during treatment with human and porcine insulin in diabetes mellitus. Lancet I: 1041–1044
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet II: 1300–1304
Chantelau E, Spraul M, Muhlhauser I, Gause R, Berger M (1989) Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin- dependent) diabetes mellitus: A one centre experience. Diabetologia 32:421–426
The Diabetes Control and Complications Trial (1988) Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? N Engl J Med 318: 246–250
Chantelau EA, Gosseringer G, Sonnenberg GE, Berger M (1985) Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia 28: 204–207
Chantelau EA, Frenzen A, Gosseringer G, Hansen I, Berger M (1987) Intensive insulin therapy justifies simplification of the diabetes diet: A prospective study in insulin-dependent diabetics: Am J Nutr 45: 958–962
Chantelau EA, Sonnenberg GE, Stanitzek-Schmidt I, Best F, Altenahr H, Berger M (1982) Diet liberalization and metabolic control in Type 1 diabetic outpatients treated by continuous subcutaneous insulin infusion. Diabetes Care 5: 612–616
The DCCT Research Group (1986) The Diabetes Control and Complications Trial (DCCT). Design and methodological considerations for the feasibility phase. Diabetes 35: 530–545
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mühlhauser, I. (1990). Normoglykämie: Immer und realistisch?. In: Dreyer, M., Dammann, HG. (eds) Vaskuläre Komplikationen und therapeutische Konsequenzen beim Diabetes mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75712-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-75712-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52597-4
Online ISBN: 978-3-642-75712-9
eBook Packages: Springer Book Archive